«Novye podkhody k vosstanovitel'nomu lecheniyu patsientovs giperaktivnym mochevym puzyrem neyrogennogo tipa» (Obzor literatury)


Cite item

Full Text

References

  1. Bycroft J, Hamid R, Bywater H, Patki P, Craggs M, Shah J. Variation in Urological Practice Amongst Spinal Injuries Units in the UK and Eire. Neurourol Urodyn 2004; 23:252-6.
  2. Brading AF. Pathophisiology of the overactive bladder. in Neurogenic Bladder ed. J. Corcos and E. Schick, Martin Dunitz, London and NewYork, 2004
  3. Bulmer P., Abrams P. The unstable detrusor //Urol.Int.-2004.-Vol.72.-P.1-12.
  4. Abrams P., Wein A.J. Neurol Urodyn 1999; 18: 413-416
  5. Abrams P, Cardoso L, Fall M et al. The standardization of terminology of low urinary tract function: report from the standardization subcommittee of the ICS. Urology 2003; 61: 37-49.
  6. Milsom I, Abrams P, Cardozo L et al. BJU Int 2001; 87: 760-6.
  7. Пушкарь Д.Ю. Гиперактивный мочевой пузырь у женщин.-М.: МЕДпресс-информ,2003
  8. Abrams P, Cardoso L, Fall M et al. The standardization of terminology of low urinary tract function: report from the standardization subcommittee of the ICS. Neurol Urodyn 2002; 21: 167-78.
  9. Block B.F.M., Willemsen A.T.M., Holstege G. Brain 1997; 20: 111-121.
  10. Bycroft J, Hamid R, Bywater H, Patki P, Craggs M, Shah J. Variation in Urological Practice Amongst Spinal Injuries Units in the UK and Eire. Neurourol Urodyn 2004; 23:252-6.
  11. Мазо Е.Б., Кривобородов Г.Г. Гиперактивный мочевой пузырь. М.: Вече,2003.
  12. Brading AF, Turner WH. Br J Urol 1994; 73: 3.
  13. Крупин В.Н., А.Н. Белова. Нейроурология: руководство для врачей.-М.: Антидор,2005.-464с.
  14. Bowden A, Colman S et al. Psychometric validation of an urgency severity scale (IUSS) for patients with overactive bladder. Neurourol Urodyn 2003; 22: abstract 119.
  15. Zinner N, Harnett M, Sabaunjian L et al. «The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder». J Urol 2005; 173: 1639-43.
  16. Donovan J.L., Abrams P., Peters T.J. et al. The ICS «BPH» study: the psychometric validity and reliabilyty of the ICH male questionare// Br.J.Urol.-1996.-Vol.77.-P.554-562.
  17. Лопаткин Н.А., Толстова С.С. Императивное недержание мочи. Материалы пленума Российского общества урологов. Ярославль. М., 2001; 5-18.
  18. Аляев Ю.Г., Винаров А.З., Гаджиева З.К., Балан В.Е. Гиперактивный мочевой пузырь. Врачебное сословие, 2004; 1-2:36-42.
  19. Аль-Шукри С. Х., Кузьмин И. В. Гиперактивность детрузора и ургентное недержание мочи: Пособие для врачей. - Санкт- Петербург, 2001. - 40 с
  20. Вишневский А.А., Лившиц А.В. Электростимуляция мочевого пузыря. М.:Медицина, 1973
  21. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 2006; 148:565-578.
  22. Кривобородов Г.Г., Мазо Е.Б., Шварц П.Г. Афферентная стимуляция тибиального нерва у больных с гиперактивным мочевым пузырем. Урология. 2002, №5. 36-39
  23. Balken M.R., Vandonichik V., Gisolf K.W. Posterior tibial nerve stimulation as neuro-modulative treatment of lower urinary tract dysfunction. J. Urol., 2001, 163(3): 914-918
  24. Мазо Е.Б., Кривобородов Г.Г. Временная сакральная нейромодуляция у больных с ургентным недержанием мочи. Урология, 2000. №4. 42-46
  25. Hassan S.T., Robson W.A., Pridie A.K., Neal D.E. Transcutaneous electrical nerve stimulation and temporary S3 neuromodulation in idiopathic detrusor instability. J. Urol., 1996; 155: 2005-2011
  26. Wein A.J. Neuromuscular dysfunction of lower urinary tract/ In:Walsh P.,Wein A. Cambells Urology.-USA:W.B.Saunders Company,1998.- P.905-1005.
  27. Schantz EJ, Johnson EA. Botulinum toxin: The Story of Its Development For the Treatment of Human Disease. Perspectives in Biology and Medicine 1997;40:317-27.
  28. Erbguth FJ, Naumann M. Historical Aspects of Botulinum Toxin: Justinus Kerner (1786-1862) and the «Sausage Poison». Neurology 1999;53: 1850-53
  29. Smith CP, Somogyi GT, Boone TB. Botulinum toxin in urology: evaluation using an evidence-based medicine approach. Nature Clinical Practice Urology 2004;1:31-37.
  30. Kuo H. Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions. Urology 2006;67: 232-36.
  31. Apostolidis A, Popat R, Yiangou Y, et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005;174(3):977-82
  32. Rapp DE, Lucioni A, Katz EE, et al. Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 2004;63(6):1071-75.
  33. Frenkl TL, Rackley RR. Injectable neuromodulatory agents: botulinum toxin therapy. Urol Clin N Am 2005;32:89-99.
  34. Reitz A, Stohrer M, Kramer G, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004;45(4):510-15.
  35. Ghei M, Maraj BH, Miller R, et al. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol 2005;174(5): 1873-77.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Rozhnevskaya E.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies